Patent Baristas

CNBC Originals goes inside the most profitable criminal enterprise in the world. An economy built on robbing U.S. businesses, costing American jobs, and bankrolling terrorism: Fake handbags, watches, and perfumes are a way of the past. The largest underground industry in the world, Counterfeit Goods bring in hundreds of billions, while sapping the economy, putting […]

The Jackson Laboratory, a biomedical research institution and repository for laboratory mice, won a summary judgment of no patent infringement against The Central Institute for Experimental Animals (CIEA). CIEA, a non-profit Japanese corporation that develops animal models used for scientific research, alleged that Jackson had infringed U.S. Pat. No. No. 7,145,055 directed to the creation […]

A survey by inovia on “US IP Trends: Global Patent Protection in 2010” show that IP budgets may now be stabilizing for 2010.  In a recent study of 150+ small to medium-sized US businesses, 72% of corporate patent professionals surveyed expect to maintain or increase their foreign patent filings in 2010, as compared to 2009. […]

An increasing awareness of the importance of intellectual property (IP) rights to business success has led to unprecedented growth and transformation in the IP sector in recent years, but where does the industry go now? In IP Review’s State of the IP Industry 2009 survey, IP professionals revealed that they were coming under increasing pressure […]

Trade secrets often represent the most valuable assets of certain companies.  The value of trade secrets continues to grow in our information-age economy as does the mobility of the work force. Both forces are increasing pressure on trade secrets. The Uniform Trade Secrets Act (UTSA), defines trade secret to mean information, including a formula, pattern, […]

Eastman’s divestment of its PET business in the EU to Indorama ended up in Delaware federal court as the licensor’s patent infringement action.  Eastman Chemical Company v. AlphaPet Inc. et al. (09-CV-971).  Named as defendants are the Indorama licensees, and affiliates, and a U.S. subsidiary, AlphaPet. The complaint raises interesting problems about a licensor suing […]

In Canada, linkage regulations similar to the Hatch-Waxman Act in the U.S. ensure that generics manufacturers have to address relevant patents listed on the Patent Register (the analog to the Orange Book) if they want to market their product prior to the expiry of listed patents.   Generics manufacturers can do so either by accepting the terms […]

Pfizer is continuing its fight with generic drug manufacturer United Laboratories, Inc. (Unilab)in the Philippines over the issue of the validity of the patent on Lipitor (atorvastatin) as Unilab tries to have the patent canceled. Unilab filed its petition for the cancellation of Philippine Patent No. 29149 for Atorvastatin, marketed under the brand name Lipitor, […]